Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-03

Clinical Trial Update: Safety and Efficacy of Oral Febuxostat in Subjects With Gout [Phase 3]

View source ↗

Summary

This is a Phase 3 trial assessing safety and efficacy of oral febuxostat in gout, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Xijing Hospital | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2016-02-03